World's Best Scientists 2026 revealed!
Masahiro Ono

Masahiro Ono

D-Index & Metrics

Chemistry

D-Index
48
Citations
10173
World Ranking
15099
National Ranking
1182

Masahiro Ono publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Masahiro Ono sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 282 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Masahiro Ono D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Masahiro Ono sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 48 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Masahiro Ono is affiliated with Kyoto University in Japan and has contributed extensively to the field of medicine, with a particular focus on radiology, nuclear medicine, and imaging. Their research portfolio encompasses over 130 publications, highlighting significant engagement in related biomedical sciences.

The main fields of study for Masahiro Ono include:

  • Medicine

Within this broad discipline, the subfields of research addressed are:

  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Oncology
  • Physiology
  • Neurology

Masahiro Ono's scientific investigations frequently cover topics such as:

  • Radiopharmaceutical Chemistry and Applications
  • Alzheimer's disease research and treatments
  • Peptidase Inhibition and Analysis
  • Monoclonal and Polyclonal Antibodies Research
  • Prostate Cancer Treatment and Research
  • Enzyme function and inhibition
  • Neuroscience and Neuropharmacology Research

The scientist has published in a range of specialized journals. Frequent publication venues include:

  • Nuclear Medicine and Biology
  • Bioorganic & Medicinal Chemistry Letters
  • ACS Medicinal Chemistry Letters
  • Journal of Medicinal Chemistry
  • ACS Chemical Neuroscience

Some of the recent research outputs by Masahiro Ono are:

  • Identification and Evaluation of Bisquinoline Scaffold as a New Candidate for α-Synuclein-PET Imaging (2020), ACS Chemical Neuroscience
  • Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen (2021), Journal of Medicinal Chemistry
  • Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties (2021), Molecular Pharmaceutics
  • First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas (2021), Frontiers in Endocrinology
  • Development of Novel 111In/225Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics (2023), Journal of Medicinal Chemistry

Collaboration is a notable aspect of their research activities. Frequent co-authors are:

  • Hiroyuki Watanabe
  • Shimpei Iikuni
  • Kazuma Nakashima
  • Yoichi Shimizu
  • Yuji Nakamoto

Best Publications

  • Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

    Shimon Sakaguchi;Masahiro Ono;Ruka Setoguchi;Haruhiko Yagi

  • Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits.

    Mengchao Cui;Masahiro Ono;Hiroyuki Watanabe;Hiroyuki Kimura

  • 11C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer’s disease

    Masahiro Ono;Alan Wilson;Jose Nobrega;David Westaway

  • BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques.

    Masahiro Ono;Hiroyuki Watanabe;Hiroyuki Kimura;Hideo Saji

  • Benzofuran derivatives as Aβ-aggregate-specific imaging agents for Alzheimer’s disease

    Masahiro Ono;Mei-Ping Kung;Catherine Hou;Hank F. Kung

  • Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.

    Masahiro Ono;Hidekazu Kawashima;Akemi Nonaka;Tomoki Kawai

  • Development of a Novel 99mTc-Chelate–Conjugated Bisphosphonate with High Affinity for Bone as a Bone Scintigraphic Agent

    Kazuma Ogawa;Takahiro Mukai;Yasuyuki Inoue;Masahiro Ono

  • Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.

    Yasushi Arano;Takashi Uezono;Hiromichi Akizawa;Masahiro Ono

  • Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides

    Hiromichi Akizawa;Yasushi Arano;Masaki Mifune;Akimasa Iwado

  • Novel 18F-Labeled Benzofuran Derivatives with Improved Properties for Positron Emission Tomography (PET) Imaging of β-Amyloid Plaques in Alzheimer’s Brains

    Masahiro Ono;Yan Cheng;Hiroyuki Kimura;Mengchao Cui

  • Radioiodinated Flavones for in Vivo Imaging of β-Amyloid Plaques in the Brain

    Masahiro Ono;Naoko Yoshida;Kenichi Ishibashi;Mamoru Haratake

  • Novel chalcones as probes for in vivo imaging of β-amyloid plaques in Alzheimer’s brains

    Masahiro Ono;Mamoru Haratake;Hiroshi Mori;Morio Nakayama

  • Synthesis and Evaluation of Novel Chalcone Derivatives with 99mTc/Re Complexes as Potential Probes for Detection of β-Amyloid Plaques

    Masahiro Ono;Ryoichi Ikeoka;Hiroyuki Watanabe;Hiroyuki Kimura

  • Aurones serve as probes of β-amyloid plaques in Alzheimer’s disease

    Masahiro Ono;Yoshifumi Maya;Mamoru Haratake;Kazuhiro Ito

  • Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals.

    Kazuma Ogawa;Takahiro Mukai;Yasushi Arano;Masahiro Ono

  • Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer’s Brains

    Masahiro Ono;Shun Hayashi;Kenji Matsumura;Hiroyuki Kimura

  • Synthesis and structure-affinity relationships of novel dibenzylideneacetone derivatives as probes for β-amyloid plaques.

    Mengchao Cui;Masahiro Ono;Hiroyuki Kimura;Boli Liu

  • Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.

    Shuntaro Oka;Hiroyuki Okudaira;Masahiro Ono;David M. Schuster

  • Technetium-99m Labeled Pyridyl Benzofuran Derivatives as Single Photon Emission Computed Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer’s Brains

    Yan Cheng;Masahiro Ono;Hiroyuki Kimura;Masashi Ueda

  • Chemical Design of Radiolabeled Antibody Fragments for Low Renal Radioactivity Levels

    Yasushi Arano;Yasushi Fujioka;Hiromichi Akizawa;Masahiro Ono

Frequent Co-Authors

Hideo Saji
Hideo Saji Kyoto University
Masafumi Ihara
Masafumi Ihara Kyoto University
Kaori Togashi
Kaori Togashi Kyoto University
Nobuya Inagaki
Nobuya Inagaki Kyoto University
Ryosuke Takahashi
Ryosuke Takahashi Kyoto University
Junji Konishi
Junji Konishi Kyoto University
Hank F. Kung
Hank F. Kung University of Pennsylvania
Yoshiaki Kiso
Yoshiaki Kiso Nagahama Institute of Bio-Science and Technology
Masahiro Hiraoka
Masahiro Hiraoka Kyoto University
Yuichi Sugiyama
Yuichi Sugiyama University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of career paths, many of which can be enhanced through specialized online degrees. For example, pursuing a paralegal degree online can complement a chemistry background for those interested in legal aspects of chemical patents or regulatory compliance.

Another promising avenue is entering the pharmaceutical industry. Learning how to get into pharmaceutical sales can be a strategic move for chemists who enjoy communication and business. This role often offers attractive salaries and opportunities for career growth.

For those committed to healthcare, becoming a pharmacist is a natural extension. Understanding how to become a pharmacist salary factors into making informed decisions about education and long-term career investment.

Additionally, careers in forensic science are accessible, with roles like autopsy technicians playing critical roles in investigations. Learning how much do autopsy techs make can help gauge the financial and educational requirements of this field.

Best Scientists Citing Masahiro Ono

Trending Scientists

Recently Published Articles